The study aims to create induced microglia-like cells (iMG) from stem cells in a controlled environment and enhance their functionality by coculturing them with retinal organoids.
Researchers established iMG production conditions, stimulated these cells, and compared their characteristics with a standard microglia cell line (HMC3) to understand their immune responses and maturation.
The results showed that iMG closely resemble primary human microglia in immune functions, and further maturation with retinal organoids (CC-iMG) led to significant improvements in their cellular activities and properties, potentially aiding future research and therapies related to microglial functions.*